Development of an LC–MS/MS method for the quantitation of deoxyglycychloxazol in rat plasma and its application in pharmacokinetic study

被引:0
作者
Rongshan Li [1 ]
Ruixue Ran [1 ]
Quansheng Li [2 ]
Yurong Huang [2 ]
Yuan Gu [2 ]
Duanyun Si [2 ]
机构
[1] Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University
[2] State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research
关键词
Deoxyglycychloxazol(TY501); LC–MS/MS; APCI; Pharmacokinetics; Rat plasma;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
1008 ;
摘要
Deoxyglycychloxazol(TY501) is a glycyrrhetinic acid derivative which exhibits high anti-inflammatory activity and reduced pseudoaldosteronism compared to glycyrrhetinic acid.In this study,a sensitive and rapid liquid chromatography–tandem mass spectrometry(LC–MS/MS) method was established for the quantitation of TY501 in rat plasma.Plasma samples were treated by precipitating protein with methanol and supernatants were separated by a Symmetry C;column with the mobile phase consisting of methanol and 10 m M ammonium formate(containing 0.1% of formic acid)(90:10,v/v).The selected reaction monitoring(SRM) transitions were performed at m/z 647.4-191.2 for TY501 and m/z 473.3-143.3 for astragaloside aglycone(IS) in the positive ion mode with atmospheric pressure chemical ionization(APCI) source.Calibration curve was linear over the concentration range of 5–5000 ng/m L.The lower limit of quantification was 5 ng/m L.The mean recovery was over 88%.The intra- and inter-day precisions were lower than 6.0% and 12.8%,respectively,and the accuracy was within 7 1.3%.TY501 was stable under usual storage conditions and handling procedure.The validated method has been successfully applied to a pharmacokinetic study after oral administration of TY501 to rats at a dosage of 10 mg/kg.
引用
收藏
页码:184 / 189
页数:6
相关论文
共 12 条
[1]   甘草次酸衍生物TY501抗肺纤维化作用及机制研究 [J].
耿艳艳 ;
于冰 ;
周植星 ;
胡倩倩 ;
徐为人 ;
汤立达 .
中国药理学通报, 2015, 31 (02) :210-215
[2]   甘草次酸及其衍生物TY501对小鼠巨噬细胞RAW264.7增殖的影响 [J].
靳如芳 ;
刘静 ;
张金晓 ;
田义红 .
药物评价研究, 2011, 34 (04) :255-257
[3]   甘草次酸衍生物对大鼠肾损伤的保护作用 [J].
崔李平 ;
王玉丽 ;
张士俊 ;
付海霞 ;
徐为人 ;
汤立达 ;
王建武 .
中草药, 2011, 42 (06) :1177-1179
[4]   甘草及甘草酸制剂引起的假性醛固酮增多症及防治 [J].
刘然 .
药物不良反应杂志, 2009, (06) :416-419
[5]  
甘草及其活性成分的药理活性研究进展 [J]. 高雪岩,王文全,魏胜利,李卫东.&nbsp&nbsp中国中药杂志. 2009(21)
[6]   新型甘草次酸异噁唑衍生物的合成 [J].
刘利军 ;
雍建平 ;
戴小军 ;
贾炯 ;
王西照 ;
王建武 .
高等学校化学学报, 2006, (09) :1669-1672
[7]   新型11-脱氧甘草次酸-30-酰胺衍生物的研究 [J].
汤立达 ;
王建武 ;
雍建平 ;
张士俊 ;
刘利军 ;
王玉丽 ;
吴楠 ;
徐为人 .
中草药, 2006, (01) :20-25
[8]   Determination of glycyrrhetic acid in human plasma by HPLC-MS method and investigation of its pharmacokinetics [J].
Zhao, W. -J. ;
Wang, B. -J. ;
Wei, C. -M. ;
Yuan, G. -Y. ;
Bu, F. -L. ;
Guo, R. -C. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2008, 33 (03) :289-294
[9]  
Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds [J] . Marjan NassiriAsl,HosseinHosseinzadeh.&nbsp&nbspPhytother. Res. . 2008 (6)
[10]  
Determination of glycyrrhetic acid in human plasma by LC–ESI–MS [J] . Li Ding,Xin Huang,Jin Yang,Xiaojie Bian,Zhengxing Zhang,Guangyu Liu.&nbsp&nbspJournal of Pharmaceutical and Biomedical Analysis . 2005 (3)